Myung‐Ju Ahn

Researcher Next ID · RN-005667

Researcher · Medicine

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Cancer Immunotherapy and Biomarkers

Lung Cancer Diagnosis and Treatment

Colorectal Cancer Treatments and Studies

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32409-7
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1612674
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)01281-7
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1501824
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1214886

No projects listed.